PHILADELPHIA and LONDON, September 24 /PRNewswire/ --

- Research of the Top 20 Companies Investing in R&D Shows Revenue
Derived from New Products Accounted for Just 16% of Total Revenue in 2006

The Centre for Medicines Research International Ltd. (CMR), a Thomson
business, today announced it has published the CMR 2007 International
Pharmaceutical R&D Factbook, an indispensable reference and business planning
tool for decision makers in pharmaceutical R&D, corporate finance, business
strategy, marketing planning and corporate communications. The Factbook
offers a comprehensive and up-to-date overview of emerging trends in 
worldwide pharmaceutical R&D, enabling users to include data in presentations 
and reports.

CMR's research of the top 20 companies investing in R&D shows that
revenue derived from new products (those launched within the last five years)
accounted for just 16% of total revenue in 2006, continuing the industry's
potential exposure to patent expiry. And although the cost of R&D continues
to rise, there's no sign of a sustained upturn in the number of new products
reaching the market. Also noteworthy this year is the continuing expansion of
clinical development in traditionally non-core countries (that is, countries
other than the eight core countries: Canada, France, Germany, Italy, Japan,
Spain, UK and US). In 2005, nearly 50% of patients recruited to clinical
trials came from these non-core regions.

"The CMR Factbook provides valuable insight into R&D activity within the
pharmaceutical industry," says Peter Joshua, vice president and general
manager, CMR International. "Our research can help users make informed
decisions that can reduce development times, improve efficiency, implement
more accurate performance target-setting and predictive modeling, and gauge
internal performance against competitors."

Underlying data found in the Factbook are exclusively from primary
sources and include all major pharmaceutical companies, which account for
approximately 80% of the industry's global R&D expenditure. The Factbook
condenses the latest learnings and analysis from CMR's uniquely comprehensive
and robust industry-wide databases. Each finding is presented in a clear,
easily-understood chart, accompanied by a succinct commentary highlighting
the key messages together with an explanation of the methodology used and the
definitions applied.

The CMR International 2007 Pharmaceutical R&D Factbook is available as a
hard copy report, or in single-user or enterprise-wide electronic format
supplied on CD. The CD contains the Factbook as both a PDF document and in
PowerPoint format, consisting of full-screen versions of each of the charts
with commentary as speaker's notes. The enterprise-wide license equips users
to distribute the complete Factbook throughout an organization and its
wholly-owned subsidiaries.

About The Thomson Corporation

The Thomson Corporation (www.thomson.com) is a global leader in providing
essential electronic workflow solutions to business and professional
customers. With operational headquarters in Stamford, Conn., Thomson provides
value-added information, software tools and applications to professionals in
the fields of law, tax, accounting, financial services, scientific research
and healthcare. The Corporation's common shares are listed on the New York
and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its
information solutions assist professionals at every stage of research and
development -- from discovery to analysis to product development and
distribution. Thomson Scientific information solutions can be found at
scientific.thomson.com.

Web site: http://www.scientific.thomson.com
              http://www.thomson.com